Open Access
Rapid Plasma Reagin Titer Variation in the 2 Weeks After Syphilis Therapy
Author(s) -
Katherine M. Holman,
Mark Wolff,
Arlene C. Seña,
David H. Martín,
Frieda Behets,
Kathleen Van Damme,
Peter A. Leone,
Linda M. McNeil,
Meredyth L. Gehrig,
Edward W. Hook
Publication year - 2012
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0b013e3182536574
Subject(s) - rapid plasma reagin , medicine , syphilis , titer , serology , penicillin , azithromycin , doxycycline , immunology , surgery , treponema , antibiotics , antibody , human immunodeficiency virus (hiv) , microbiology and biotechnology , biology
Serologic tests for syphilis results at the time of diagnosis are the basis for evaluating response to syphilis therapy. After treatment, however, serologic tests for syphilis titers may continue to increase for several weeks. We evaluated rapid plasma reagin (RPR) titer variation during the 14 days after therapy using data from a recent large, prospective randomized controlled trial.